AI Generated Image
Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million
The New York Times • • business
Key Points:
- Chai Discovery, a rapidly growing AI company focused on drug design, has raised $400 million in new funding, valuing the company at $3.8 billion.
- The funding round was led by Index Ventures and included major investors such as Kleiner Perkins, Sequoia Capital, Bain Capital Ventures, Thrive Capital, OpenAI, and Yosemite.
- This investment reflects growing interest in AI applications within life sciences, with experts like Index partner Nina Achadjian emphasizing AI’s potential impact on drug discovery.
- Chai Discovery is part of a competitive landscape that includes Isomorphic Labs, a Google spinoff that has raised $2.7 billion since March 2025, leveraging Nobel-winning technology for drug development.
